Watson, Philip A.
Arora, Vivek K.
Sawyers, Charles L.
Article History
First Online: 13 November 2015
Competing interests
: P.A.W. owns stock in Tokai Pharmaceuticals. C.L.S. is an inventor of patents covering enzalutamide and ARN-509 and is entitled to royalties. He also serves on the Board of Directors of Novartis. V.K.A. declares no competing interests.